Trials / Conditions / Residual Neuromuscular Block

Residual Neuromuscular Block

8 registered clinical trials studyying Residual Neuromuscular Block — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary Function NCT07309393	Shanghai Pulmonary Hospital, Shanghai, China	N/A
Active Not Recruiting	Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Propofol Anesthesia NCT07044180	Tamas Vegh, MD	Phase 4
Not Yet Recruiting	Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Sevoflurane Anesthesia NCT07044193	Tamas Vegh, MD	Phase 4
Enrolling By Invitation	Measuring of the Duration of Action of Different Doses of Rocuronium-induced Neuromuscular Block in Infants Du NCT07080528	Tamas Vegh, MD	Phase 4
Completed	Effects of Low-pressure Pneumoperitoneum Associated With Deep Pipecuronium-induced Neuromuscular Blockade on H NCT06517524	Tamas Vegh, MD	—
Unknown	Comparison of Sugammadex and Sugammadex-neostigmine Combination in the Antagonism of Moderate Neuromuscular Bl NCT05228223	Ankara City Hospital Bilkent	N/A
Completed	Neostigmine Reversal And Neuromuscular Recovery NCT02433808	Endeavor Health	Phase 4
Completed	Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postopera NCT01651572	Azienda Ospedaliera di Padova	Phase 4